Literature DB >> 33551718

The Effects of Extracorporeal Shock Wave Therapy on Spastic Muscle of the Wrist Joint in Stroke Survivors: Evidence From Neuromechanical Analysis.

Yan Leng1, Wai Leung Ambrose Lo1, Chengpeng Hu1, Ruihao Bian1, Zhiqin Xu1, Xiyao Shan1, Dongfeng Huang2, Le Li1,3.   

Abstract

Background: This study combined neuromechanical modeling analysis, muscle tone measurement from mechanical indentation and electrical impedance myography to assess the neural and peripheral contribution to spasticity post stroke at wrist joint. It also investigated the training effects and explored the underlying mechanism of radial extracorporeal shock wave (rESW) on spasticity.
Methods: People with first occurrence of stroke were randomly allocated to rESW intervention or control group. The intervention group received one session of rESW therapy, followed by routine therapy which was the same frequency and intensity as the control group. Outcome measures were: (1) NeuroFlexor method measured neural component (NC), elastic component (EC) and viscosity component (VC), and (2) myotonometer measured muscle tone (F) and stiffness (S), (3) electrical impedance myography measured resistance (R), reactance (X) and phase angle (θ); (4) modified Asworth scale; (5) Fugl Meyer Upper limb scale. All outcome measures were recorded at baseline, immediately post rESW and at 1-week follow-up. The differences between the paretic and non-paretic side were assessed by t-test. The effectiveness of rESW treatment were analyzed by repeated-measures one-way analysis of variance (ANOVA) at different time points.
Results: Twenty-seven participants completed the study. NC, EC, and VC of the Neuroflexor method, F and S from myotonometer were all significantly higher on the paretic side than those from the non-paretic side. R, X, and θ from electrical impedance were significantly lower on the paretic side than the non-paretic side. Immediately after rESW intervention, VC, F, and S were significantly reduced, and X was significantly increased. The clinical scores showed improvements immediate post rESW and at 1-week follow-up. Conclusions: The observed changes in upper limb muscle properties adds further support to the theory that both the neural and peripheral components play a role in muscle spasticity. ESW intervention may be more effective in addressing the peripheral component of spasticity in terms of muscle mechanical properties changes. The clinical management of post stroke spasticity should take into consideration of both the neural and non-neural factors in order to identify optimal intervention regime.
Copyright © 2021 Leng, Lo, Hu, Bian, Xu, Shan, Huang and Li.

Entities:  

Keywords:  extracorporeal shock ware therapy; muscle mechanical properties; neurorehabilitation; spasticity; stroke; upper extremities

Year:  2021        PMID: 33551718      PMCID: PMC7859269          DOI: 10.3389/fnins.2020.580762

Source DB:  PubMed          Journal:  Front Neurosci        ISSN: 1662-453X            Impact factor:   4.677


  67 in total

1.  Electrical impedance myography for the in vivo and ex vivo assessment of muscular dystrophy (mdx) mouse muscle.

Authors:  Jia Li; Tom R Geisbush; Glenn D Rosen; Jennifer Lachey; Aaron Mulivor; Seward B Rutkove
Journal:  Muscle Nerve       Date:  2014-06       Impact factor: 3.217

2.  Effect of radial shock wave therapy on pain and muscle hypertonia: a double-blind study in patients with multiple sclerosis.

Authors:  L Marinelli; L Mori; C Solaro; A Uccelli; E Pelosin; A Currà; L Molfetta; G Abbruzzese; C Trompetto
Journal:  Mult Scler       Date:  2014-09-25       Impact factor: 6.312

3.  Focused low-energy extracorporeal shock waves with distally symmetric polyneuropathy (DSPNP): a pilot study.

Authors:  H Lohse-Busch; E Marlinghaus; U Reime; U Möwis
Journal:  NeuroRehabilitation       Date:  2014-01-01       Impact factor: 2.138

4.  Extracorporeal shockwave therapy on muscle tissue: the effects on healthy athletes.

Authors:  A Notarnicola; I Covelli; G Maccagnano; R Marvulli; L Mastromauro; G Ianieri; S Boodhoo; A Turitto; L Petruzzella; G Farì; F P Bianchi; S Tafuri; B Moretti
Journal:  J Biol Regul Homeost Agents       Date:  2018 Jan-Feb       Impact factor: 1.711

5.  Long-term effect of shock wave therapy on upper limb hypertonia in patients affected by stroke.

Authors:  P Manganotti; E Amelio
Journal:  Stroke       Date:  2005-08-18       Impact factor: 7.914

Review 6.  Structural and functional changes in spastic skeletal muscle.

Authors:  Richard L Lieber; Suzanne Steinman; Ilona A Barash; Hank Chambers
Journal:  Muscle Nerve       Date:  2004-05       Impact factor: 3.217

7.  Extracorporeal shock wave therapy for the treatment of poststroke plantar-flexor muscles spasticity: a prospective open-label study.

Authors:  Andrea Santamato; Maria Francesca Micello; Francesco Panza; Francesca Fortunato; Giancarlo Logroscino; Alessandro Picelli; Paolo Manganotti; Nicola Smania; Pietro Fiore; Maurizio Ranieri
Journal:  Top Stroke Rehabil       Date:  2014       Impact factor: 2.119

8.  Extracorporeal Shock Wave Therapy reduces upper limb spasticity and improves motricity in patients with chronic hemiplegia: a case series.

Authors:  Franco Troncati; Matteo Paci; Tefta Myftari; Bruna Lombardi
Journal:  NeuroRehabilitation       Date:  2013       Impact factor: 2.138

Review 9.  Spastic movement disorder: impaired reflex function and altered muscle mechanics.

Authors:  Volker Dietz; Thomas Sinkjaer
Journal:  Lancet Neurol       Date:  2007-08       Impact factor: 44.182

10.  Clinical study of combined mirror and extracorporeal shock wave therapy on upper limb spasticity in poststroke patients.

Authors:  Junyi Guo; Shuyan Qian; Yisu Wang; Aihua Xu
Journal:  Int J Rehabil Res       Date:  2019-03       Impact factor: 1.479

View more
  1 in total

1.  Extracorporeal Shock Wave Therapy on Spasticity After Upper Motor Neuron Injury: A Systematic Review and Meta-analysis.

Authors:  Hui-Ling Zhang; Rong-Jiang Jin; Li Guan; Dong-Ling Zhong; Yu-Xi Li; Xiao-Bo Liu; Qi-Wei Xiao; Xi-Li Xiao; Juan Li
Journal:  Am J Phys Med Rehabil       Date:  2022-02-15       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.